Publications by authors named "Tengfei Ge"

Article Synopsis
  • A new grading system for lung cancer has been created by the International Association for the Study of Lung Cancer (IASLC) to help doctors decide on surgeries.
  • Researchers looked at how well different doctors agreed on this grading system by reviewing samples from patients with lung adenocarcinoma (a type of lung cancer).
  • The study found that doctors generally agreed quite well on the grades, which helps predict patient outcomes like survival, and it suggests that using these grades during surgeries might be a good idea for future research.
View Article and Find Full Text PDF

Background: The results of how matrix metalloproteinases (MMPs) polymorphisms affect esophageal cancer (EC) risk are not consistent, especially for MMP1,2,7 and 9. A meta-analysis focused on the impact of MMPs to digestive cancers, but not a precise analysis to EC, therefore, we designed the current study to make a clear understanding of the association between MMPs polymorphisms and EC.

Methods: Up to March 2020, we searched several databases to find case-control cohorts concerned about the risk of MMPs polymorphisms to EC risk.

View Article and Find Full Text PDF

Background: The prevalence and cancer-specific death rate of lung cancer (LC) have risen in recent decades. A universally applicable prognostic signature for both adenocarcinoma LC (LUAD) and squamous cell carcinoma LC (LUSC) is still lacking.

Methods: A total of 453 patients from The Cancer Genome Atlas (TCGA)-LUAD cohort and 452 patients from TCGA-LUSC cohort were enrolled, and a prognostic model was constructed using least absolute shrinkage and selection operator (LASSO) regression analysis based on the consensus prognostic genes in both cohorts.

View Article and Find Full Text PDF

Background: LncRNA DLGAP1-AS2 plays an oncogenic role in glioma, while its role in other cancers is unknown. This study aimed to study the role of DLGAP1-AS2 in non-small cell lung cancer (NSCLC).

Methods: Expression of DLGAP1-AS2 in NSCLC and paired non-tumor tissues from 64 NSCLC patients and the prognostic value of DLGAP1-AS2 for NSCLC were analyzed by performing a 5-year follow-up study.

View Article and Find Full Text PDF